Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
Clinical trial NCT02749890 · COMPLETED
Trial details
- NCT number
- NCT02749890
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-09
- Primary completion
- 2018-05-01
- Enrollment
- 321
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.